It confirms that MLH1 and MSH2 give the highest cancer risks, mainly but not only limited to CRC incidence, and as presented in the clinical case earlier in this article, MSH2 is known to be more connected to extra-intestinal presentations than other LS genes [30,31]. Here, MLH1 is linked to cancer.